REZDIFFRA

Drug Madrigal Pharmaceuticals
Total Payments
$4.1M
Transactions
5,918
Doctors
2,540
Companies
1

Payment Trends by Year

Year Amount Transactions Doctors
2024 $4.1M 5,918 2,540

Payments by Nature

Nature of Payment Amount Transactions Share
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $3.0M 1,071 74.1%
Food and Beverage $403,461 3,452 9.9%
Travel and Lodging $365,575 1,135 9.0%
Honoraria $194,633 44 4.8%
Consulting Fee $41,214 66 1.0%
Space rental or facility fees (teaching hospital only) $40,750 7 1.0%
Education $5,999 141 0.1%
Grant $5,000 2 0.1%

Top Doctors Receiving Payments for REZDIFFRA — Page 3

Doctor Specialty Location Total Records
, MD Hepatology Tyler, TX $19,061 16
, MD Gastroenterology Flowood, MS $18,812 14
, MD Transplant Hepatology Valhalla, NY $18,776 19
, MD,PHD,MBA Gastroenterology New York, NY $18,699 20
, MD Hepatology New York, NY $18,615 17
, M.D Gastroenterology Englewood, CO $18,137 20
, M.D Gastroenterology Birmingham, AL $18,092 12
, MD Hepatology Berkeley, CA $18,027 20
, DNP Family San Antonio, TX $17,748 23
, MD Gastroenterology Wynnewood, PA $17,252 13
, M.D Endocrinology, Diabetes & Metabolism Smithtown, NY $17,219 28
, M.D Gastroenterology Philadelphia, PA $17,152 18
, MD Gastroenterology Chicago, IL $17,122 14
, M.D Gastroenterology Germantown, TN $16,985 9
, M.D Internal Medicine Houston, TX $16,966 10
, M.D Hepatology Mcallen, TX $16,842 8
, MD Gastroenterology Columbus, OH $16,593 15
, M.D Hepatology Cranston, RI $16,520 15
, MD Gastroenterology Newport News, VA $16,519 15
, M.D Transplant Hepatology Johnson City, TN $15,934 6
, M.D Internal Medicine Houston, TX $15,910 12
, MD, MPH, FACP Hepatology Philadelphia, PA $15,880 14
, MD Transplant Surgery Los Angeles, CA $15,830 16
, MD Hepatology Newark, NJ $15,829 17
, M.D Hepatology Coronado, CA $15,805 14

About REZDIFFRA

REZDIFFRA is a drug associated with $4.1M in payments to 2,540 healthcare providers, recorded across 5,918 transactions in the CMS Open Payments database. The primary manufacturer is Madrigal Pharmaceuticals.

Payment data is available from 2024 to 2024. In 2024, $4.1M was paid across 5,918 transactions to 2,540 doctors.

The most common payment nature for REZDIFFRA is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($3.0M, 74.1% of total).